(Q36165291)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15960772%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

review article

1 reference

title

Mental health policy and psychotropic drugs (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15960772%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15960772%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

author name string

Richard G Frank

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15960772%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Howard H Goldman

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15960772%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

language of work or name

English

0 references

publication date

1 January 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15960772%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15960772%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

volume

83

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15960772%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15960772%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

page(s)

271-298

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15960772%20AND%20SRC:MED&resulttype=core&format=json

Predictability of prescription drug expenditures for Medicare beneficiaries.

13 January 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2690138

The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R)

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2690138

Specialty health care, treatment patterns, and quality: the impact of a mental health carve-out on care for depression

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2690138

Cost-effectiveness of antidepressant medications

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2690138

Abnormalities in glucose regulation during antipsychotic treatment of schizophrenia

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2690138

The strategic response by pharmaceutical firms to the Medicaid most-favored-customer rules

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2690138

Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: a review and meta-analysis of randomized trials

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2690138

Antipsychotic-induced weight gain: a comprehensive research synthesis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2690138

Novel antipsychotics: comparison of weight gain liabilities.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2690138

Patterns of usual care for schizophrenia: initial results from the Schizophrenia Patient Outcomes Research Team (PORT) Client Survey

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2690138

Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2690138

Patterns of antidepressant use in community practice

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2690138

Promotion of prescription drugs to consumers.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2690138

Alternative insurance arrangements and the treatment of depression: what are the facts?

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2690138

Selective serotonin reuptake inhibitors: meta-analysis of discontinuation rates.

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2690138

Treatment discontinuation with selective serotonin reuptake inhibitors compared with tricyclic antidepressants: a meta-analysis

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2690138

Treatments of depression and the functional capacity to work.

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2690138

The effect of a managed behavioral health carve-out on quality of care for medicaid patients diagnosed as having schizophrenia

2 July 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-0009.2005.00347.X

Effects of pharmaceutical promotion on adherence to the treatment guidelines for depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-0009.2005.00347.X

Do new prescription drugs pay for themselves? The case of second-generation antipsychotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-0009.2005.00347.X

Clozapine use in patients with schizophrenia and the risk of diabetes, hyperlipidemia, and hypertension: a claims-based approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-0009.2005.00347.X

A comparison of clozapine and haloperidol in hospitalized patients with refractory schizophrenia. Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-0009.2005.00347.X

Impact of disseminating quality improvement programs for depression in managed primary care: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-0009.2005.00347.X

U.S. spending for mental health and substance abuse treatment, 1991-2001.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2690138

Adverse selection and the challenges to stand-alone prescription drug insurance

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2690138

Direct-to-Consumer Advertising — Education or Emotion Promotion?

23 September 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-0009.2005.00347.X

Risk Sharing In Managed Behavioral Health Care

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-0009.2005.00347.X

Direct-to-consumer advertising--strengthening our health care system

21 January 2018

1 reference

12 December 2020

Adequacy and duration of antidepressant treatment in primary care

1 reference

12 December 2020

The cost of treatment dropout in depression. A cost-benefit analysis of fluoxetine vs. tricyclics

1 reference

12 December 2020

The efficacy of selective serotonin re-uptake inhibitors in depression: a meta-analysis of studies against tricyclic antidepressants

1 reference

12 December 2020

Improvement in subjective work performance after treatment of chronic depression: some preliminary results. Chronic Depression Study Group

1 reference

12 December 2020

10.1111/J.1468-0009.2005.00347.X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15960772%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15960772%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

PubMed publication ID

15960772

1 reference